Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants.
Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants.
复制标题
DOI:
10.1016/j.bbi.2012.12.012
复制
发表时间:
2013-03
期刊:
影响因子:
--
通讯作者:
ELGAN Study Investigators
中科院分区:
文献类型:
--
作者:
O'Shea TM;Shah B;Allred EN;Fichorova RN;Kuban KCK;Dammann O;Leviton A;ELGAN Study Investigators
Neonatal inflammation is associated with perinatal brain damage. We evaluated to what extent elevated blood levels of inflammation-related proteins supplement information about the risk of impaired early cognitive function provided by inflammation-related illnesses. From 800 infants born before the 28th week of gestation, we collected blood spots on days 1, 7 and 14, for analysis of 25 inflammation-related proteins, and data about culture-positive bacteremia, necrotizing enterocolitis (Bell stage IIIb), and isolated perforation of the intestine, during the first two weeks, and whether they were ventilated on postnatal day 14. We considered a protein to be persistently or recurrently elevated if its concentration was in the top quartile (for gestational age and day blood was collected) on two separate days one week apart. We assessed the children at 2 years of age with the Bayley Mental Development Index (MDI). The combinations of NEC and ventilation on day 14, and of bacteremia and ventilation on day 14 consistently provided information about elevated risk of MDI <55, regardless of whether or not a variable for an elevated protein concentration was included in the model. A variable for a persistently or recurrently elevated concentration of each of the following proteins provided additional information about an increased risk of MDI <55: CRP, SAA, IL-6, TNF-alpha, IL-8, MIP-1beta, ICAM-1, E-SEL, and IGFBP-1. We conclude that elevated blood concentrations of inflammation-related proteins provide information about the risk of impaired cognitive function at age 2 years that supplements information provided by inflammation-associated illnesses.
登录
查看更多内容
影响因子:
2.1
作者:
Dammann O;O'Shea TM
通讯作者:
O'Shea TM
影响因子:
1.9
作者:
Kaindl AM;Favrais G;Gressens P
通讯作者:
Gressens P
影响因子:
2.3
作者:
Kuban, Karl;Adler, Ira;Leviton, Alan
通讯作者:
Leviton, Alan
影响因子:
2.1
作者:
Fairchild KD;O'Shea TM
通讯作者:
O'Shea TM
影响因子:
158.5
作者:
Brocklehurst, Peter;Farrell, Barbara;Tarnow-Mordi, William
通讯作者:
Tarnow-Mordi, William